HIV drug reduces graft-vs.-host disease in bone marrow transplant patients
An HIV drug that redirects immune cell traffic significantly reduces the incidence of a dangerous complication that often follows bone marrow transplants for blood cancer patients, according to research from the Perelman ...
Jul 11, 2012
0
0